The publications on this site are part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Informa
Skip to Page Content

Companies

Search All Companies »

Find a Company by Name

View All Companies

All
Industries

Biotechnology

Email Alert | RSS Feed

Alliqua BioMedical Inc. / See Company Profile

Acquisition / Adynxx reverse merges with Alliqua, taking the latter's public listing to advance pain pipeline / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 15, 2018

Acquisition / Celularity buys Alliqua’s wound care business for $29mm / Strategic Transactions / Deal Date: Jan. 1, 2018 / Publish Date: Jan. 19, 2018

Alliance / Argentum buys TheraBond line from Alliqua for $3.8mm / Strategic Transactions / Deal Date: Sep. 1, 2017 / Publish Date: Sep. 6, 2017

Rgenix Inc. / See Company Profile

Financing / Rgenix closes $40mm Series C round / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 10, 2018

Financing / Rgenix raises $33mm through Series B round / Strategic Transactions / Deal Date: Jun. 1, 2016 / Publish Date: Jun. 17, 2016

Financing / Rgenix closes $8mm Series A round / Strategic Transactions / Deal Date: Aug. 1, 2015 / Publish Date: Jun. 17, 2016

Iovance Biotherapeutics Inc. / See Company Profile

Financing / Public offering nets $237mm for Iovance / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 15, 2018

Financing / Iovance nets $162mm through follow-on offering / Strategic Transactions / Deal Date: Jan. 1, 2018 / Publish Date: Jan. 27, 2018

Financing / Public offering nets $54mm for Iovance / Strategic Transactions / Deal Date: Sep. 1, 2017 / Publish Date: Sep. 22, 2017


Medical Devices

Email Alert | RSS Feed

Stryker Corp. / See Company Profile

Acquisition / Stryker acquires dural sealant maker HyperBranch for $220mm / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 5, 2018

Acquisition / Stryker buys K2M for $1.4bn / Strategic Transactions / Deal Date: Aug. 1, 2018 / Publish Date: Oct. 4, 2018

Acquisition / Stryker to acquire surgical device maker Invuity for $190mm / Strategic Transactions / Deal Date: Sep. 1, 2018 / Publish Date: Sep. 12, 2018

Teleflex Inc. / See Company Profile

Acquisition / Teleflex buys Essential Medical / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 5, 2018

Alliance / Teleflex acquires products from QT Vascular, gets option to another / Strategic Transactions / Deal Date: May 1, 2018 / Publish Date: May 30, 2018

Financing / Teleflex nets $493.7mm in senior notes offering / Strategic Transactions / Deal Date: Nov. 1, 2017 / Publish Date: Nov. 21, 2017

SeaSpine Holdings Corp. / See Company Profile

Financing / SeaSpine nets $47.4mm via FOPO / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 12, 2018

Acquisition / SeaSpine acquires NLT Spine / Strategic Transactions / Deal Date: Aug. 1, 2016 / Publish Date: Sep. 14, 2016

Financing / SeaSpine enters $30mm credit facility agreement with Wells Fargo / Strategic Transactions / Deal Date: Dec. 1, 2015 / Publish Date: Dec. 29, 2015


In Vitro Diagnostics

Email Alert | RSS Feed

Quest Diagnostics Inc. / See Company Profile

Acquisition / Quest buys Oxford Immunotec's US lab services biz / Strategic Transactions / Deal Date: Sep. 1, 2018 / Publish Date: Sep. 27, 2018

Acquisition / DiaSorin acquires molecular and immunoassay business from Quest Diagnostics / Strategic Transactions / Deal Date: Mar. 1, 2016 / Publish Date: Apr. 13, 2016

Acquisition / Corning divests its Clinical Labs and Pharma Services divisions / Strategic Transactions / Deal Date: May 1, 1996 / Publish Date: Apr. 1, 2016

Epizyme Inc. / See Company Profile

Financing / Public offering nets $81mm for Epizyme / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 4, 2018

Financing / Epizyme nets $151mm through public stock sale / Strategic Transactions / Deal Date: Sep. 1, 2017 / Publish Date: Sep. 15, 2017

Alliance / Epizyme to test tazemetostat combination with Roche/Genentech's Tecentriq / Strategic Transactions / Deal Date: Jun. 1, 2016 / Update Date: Jun. 1, 2017

Glympse Bio Inc. / See Company Profile

Financing / Glympse Bio raises $22mm through Series A round / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 16, 2018

Financing / Glympse Bio gets $6.6mm in seed funding / Strategic Transactions / Deal Date: Dec. 1, 2015 / Publish Date: Oct. 16, 2018


Pharmaceuticals

Email Alert | RSS Feed

Sarepta Therapeutics Inc. / See Company Profile

Alliance / Sarepta gains ex-European license to Lysogene's LYS-SAF302 MPS IIIA gene therapy candidate / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 16, 2018

Alliance / Sarepta licenses Pompe program from Lacerta, options two CNS candidates / Strategic Transactions / Deal Date: Aug. 1, 2018 / Publish Date: Aug. 10, 2018

Alliance / Sarepta licenses five LGMD gene therapy candidates from Myonexus; has option to buy company / Strategic Transactions / Deal Date: May 1, 2018 / Publish Date: May 7, 2018

Aclaris Therapeutics Inc. / See Company Profile

Financing / Aclaris nets $87mm through FOPO / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 19, 2018

Alliance / Aclaris gains Allergan's Rhofade rosacea drug / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 18, 2018

Financing / Aclaris enters $65mm loan facility to fund Rhofade buy / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 18, 2018

Acasti Pharma Inc. / See Company Profile

Financing / Acasti nets $17.8mm in US follow-on / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 9, 2018

Financing / Acasti nets $Cdn22.6mm through public financing in Canada / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 9, 2018

Financing / Acasti nets $10mm via FOPO / Strategic Transactions / Deal Date: Dec. 1, 2017 / Publish Date: Jan. 4, 2018

Biotechnology

Biotechnology

Email Alert | RSS Feed

Alliqua BioMedical Inc. / See Company Profile

Acquisition / Adynxx reverse merges with Alliqua, taking the latter's public listing to advance pain pipeline / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 15, 2018

Acquisition / Celularity buys Alliqua’s wound care business for $29mm / Strategic Transactions / Deal Date: Jan. 1, 2018 / Publish Date: Jan. 19, 2018

Alliance / Argentum buys TheraBond line from Alliqua for $3.8mm / Strategic Transactions / Deal Date: Sep. 1, 2017 / Publish Date: Sep. 6, 2017

Rgenix Inc. / See Company Profile

Financing / Rgenix closes $40mm Series C round / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 10, 2018

Financing / Rgenix raises $33mm through Series B round / Strategic Transactions / Deal Date: Jun. 1, 2016 / Publish Date: Jun. 17, 2016

Financing / Rgenix closes $8mm Series A round / Strategic Transactions / Deal Date: Aug. 1, 2015 / Publish Date: Jun. 17, 2016

Iovance Biotherapeutics Inc. / See Company Profile

Financing / Public offering nets $237mm for Iovance / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 15, 2018

Financing / Iovance nets $162mm through follow-on offering / Strategic Transactions / Deal Date: Jan. 1, 2018 / Publish Date: Jan. 27, 2018

Financing / Public offering nets $54mm for Iovance / Strategic Transactions / Deal Date: Sep. 1, 2017 / Publish Date: Sep. 22, 2017

Medical
Devices

Medical Devices

Email Alert | RSS Feed

Stryker Corp. / See Company Profile

Acquisition / Stryker acquires dural sealant maker HyperBranch for $220mm / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 5, 2018

Acquisition / Stryker buys K2M for $1.4bn / Strategic Transactions / Deal Date: Aug. 1, 2018 / Publish Date: Oct. 4, 2018

Acquisition / Stryker to acquire surgical device maker Invuity for $190mm / Strategic Transactions / Deal Date: Sep. 1, 2018 / Publish Date: Sep. 12, 2018

Teleflex Inc. / See Company Profile

Acquisition / Teleflex buys Essential Medical / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 5, 2018

Alliance / Teleflex acquires products from QT Vascular, gets option to another / Strategic Transactions / Deal Date: May 1, 2018 / Publish Date: May 30, 2018

Financing / Teleflex nets $493.7mm in senior notes offering / Strategic Transactions / Deal Date: Nov. 1, 2017 / Publish Date: Nov. 21, 2017

SeaSpine Holdings Corp. / See Company Profile

Financing / SeaSpine nets $47.4mm via FOPO / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 12, 2018

Acquisition / SeaSpine acquires NLT Spine / Strategic Transactions / Deal Date: Aug. 1, 2016 / Publish Date: Sep. 14, 2016

Financing / SeaSpine enters $30mm credit facility agreement with Wells Fargo / Strategic Transactions / Deal Date: Dec. 1, 2015 / Publish Date: Dec. 29, 2015

In Vitro
Diagnostics

In Vitro Diagnostics

Email Alert | RSS Feed

Quest Diagnostics Inc. / See Company Profile

Acquisition / Quest buys Oxford Immunotec's US lab services biz / Strategic Transactions / Deal Date: Sep. 1, 2018 / Publish Date: Sep. 27, 2018

Acquisition / DiaSorin acquires molecular and immunoassay business from Quest Diagnostics / Strategic Transactions / Deal Date: Mar. 1, 2016 / Publish Date: Apr. 13, 2016

Acquisition / Corning divests its Clinical Labs and Pharma Services divisions / Strategic Transactions / Deal Date: May 1, 1996 / Publish Date: Apr. 1, 2016

Epizyme Inc. / See Company Profile

Financing / Public offering nets $81mm for Epizyme / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 4, 2018

Financing / Epizyme nets $151mm through public stock sale / Strategic Transactions / Deal Date: Sep. 1, 2017 / Publish Date: Sep. 15, 2017

Alliance / Epizyme to test tazemetostat combination with Roche/Genentech's Tecentriq / Strategic Transactions / Deal Date: Jun. 1, 2016 / Update Date: Jun. 1, 2017

Glympse Bio Inc. / See Company Profile

Financing / Glympse Bio raises $22mm through Series A round / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 16, 2018

Financing / Glympse Bio gets $6.6mm in seed funding / Strategic Transactions / Deal Date: Dec. 1, 2015 / Publish Date: Oct. 16, 2018

Pharmaceuticals

Pharmaceuticals

Email Alert | RSS Feed

Sarepta Therapeutics Inc. / See Company Profile

Alliance / Sarepta gains ex-European license to Lysogene's LYS-SAF302 MPS IIIA gene therapy candidate / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 16, 2018

Alliance / Sarepta licenses Pompe program from Lacerta, options two CNS candidates / Strategic Transactions / Deal Date: Aug. 1, 2018 / Publish Date: Aug. 10, 2018

Alliance / Sarepta licenses five LGMD gene therapy candidates from Myonexus; has option to buy company / Strategic Transactions / Deal Date: May 1, 2018 / Publish Date: May 7, 2018

Aclaris Therapeutics Inc. / See Company Profile

Financing / Aclaris nets $87mm through FOPO / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 19, 2018

Alliance / Aclaris gains Allergan's Rhofade rosacea drug / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 18, 2018

Financing / Aclaris enters $65mm loan facility to fund Rhofade buy / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 18, 2018

Acasti Pharma Inc. / See Company Profile

Financing / Acasti nets $17.8mm in US follow-on / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 9, 2018

Financing / Acasti nets $Cdn22.6mm through public financing in Canada / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 9, 2018

Financing / Acasti nets $10mm via FOPO / Strategic Transactions / Deal Date: Dec. 1, 2017 / Publish Date: Jan. 4, 2018

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel